Unbound MEDLINE

Three-year cost analysis of function-centred versus pain-centred inpatient rehabilitation in patients with chronic non-specific low back pain. Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine [J Rehabil Med] Journal article

 
TitleThree-year cost analysis of function-centred versus pain-centred inpatient rehabilitation in patients with chronic non-specific low back pain.
Author(s)Bachmann S, Wieser S, Oesch P, Schmidhauser S, Knüsel O, Kool J 
InstitutionKlinik für Rheumatologie und Rehabilitation des Bewegungsapparates, Rehabilitationszentrum Klinik Valens, CH-7317 Valens, Switzerland. E-mail: s.bachmann@klinik-valens.ch.
SourceJ Rehabil Med 2009 Nov; 41(11):919-23.
AbstractOBJECTIVE: To compare costs of function- and pain-centred inpatient treatment in patients with chronic low back pain over 3 years of follow-up.
DESIGN: Cost analysis of a randomized controlled trial.
PATIENTS: A total of 174 patients with chronic low back pain were randomized to function- or pain-centred inpatient treatment.
METHODS: Data on direct and indirect costs were gathered by questionnaires sent to patients, health insurance providers, employers, and the Swiss Disability Insurance Company.
RESULTS: There was a non-significant difference in total medical costs after 3 years' follow-up. Total costs were 77,305 Euros in the function-centred inpatient treatment group and 83,085 Euros in the pain-centred inpatient treatment group. Likewise, indirect costs after 3 years from lost work days were non-significantly lower in the function-centred in-patient treatment group (6354 Euros; 95% confidence interval -20,892, 8392) and direct medical costs were non-significantly higher in the function-centred inpatient treatment group (574 Euros; 95% confidence interval -862, 2011).
CONCLUSION: The total costs of function-centred and pain-centred inpatient treatment were similar over the whole 3-year follow-up.
Languageeng
Pub Type(s)Journal Article
PubMed ID19841844
  
Advertise on this site.